Answers are grounded in this paper and cite their sources.
A nationwide survey and recent information documented 57 patients with Creutzfeldt-Jakob disease (CJD) who had received dura mater grafts during the period between January 1979 and September 1999. At least 54 of these 57 patients received the same brand of dura mater graft from the same processor. Mean age at disease onset in the 57 patients with dural grafts was younger (51.9 years) than that in patients with sporadic CJD (63 years) (p < 0. 0001). Initial symptoms were cerebellar ataxia, disorientation, and visual or oculomotor disturbance.
No takes yet. Share an insight, caveat, or question.
Hoshi et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: